| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 1.104.182.260 $ | +383.401.930 $ | +67,5 % | 58 | 759.221.131 $ | +39.312.722 $ | +64,5 % | 53 | 757.893.709 $ | +757.893.709 $ | 54 | ||||
| Liquidia Corp | LQDA | → 0 | Sehr schwach | 195.139.175 $ | +106.318.675 $ | +119,7 % | 1 | 88.820.500 $ | +3.839.000 $ | +4,5 % | 1 | 84.981.500 $ | +84.981.500 $ | 1 | |
| HARROW, INC. | HROW | → 0 | Neutral | 101.928.000 $ | +2.063.570 $ | +2,1 % | 1 | 99.864.430 $ | -91.480.570 $ | -47,8 % | 1 | 191.345.000 $ | +191.345.000 $ | 1 | |
| Eton Pharmaceuticals, Inc. | ETON | → 0 | Neutral | 103.532.000 $ | +32.947.200 $ | +46,7 % | 1 | 70.584.800 $ | +22.222.200 $ | +45,9 % | 1 | 48.362.600 $ | +48.362.600 $ | 1 | |
| Disc Medicine, Inc. | IRON | → 0 | Neutral | 62.534.700 $ | +35.615.960 $ | +132,3 % | 1 | 26.918.740 $ | +11.036.740 $ | +69,5 % | 1 | 15.882.000 $ | +15.882.000 $ | 1 | |
| UroGen Pharma Ltd. | URGN | → 0 | Schwach | 52.991.853 $ | +27.280.453 $ | +106,1 % | 1 | 25.711.400 $ | +19.424.933 $ | +309,0 % | 1 | 6.286.467 $ | +6.286.467 $ | 1 | |
| Apogee Therapeutics, Inc. | APGE | → 0 | 51.764.700 $ | +18.938.400 $ | +57,7 % | 1 | 32.826.300 $ | +3.520.662 $ | +12,0 % | 1 | 29.305.638 $ | +29.305.638 $ | 1 | ||
| MeiraGTx Holdings plc | MGTX | → 0 | Neutral | 47.960.500 $ | +29.573.077 $ | +160,8 % | 1 | 18.387.423 $ | +15.280.213 $ | +491,8 % | 1 | 3.107.210 $ | +3.107.210 $ | 1 | |
| Sol-Gel Technologies Ltd. | SLGL | → 0 | Neutral | 37.070.000 $ | -2.540.000 $ | -6,4 % | 1 | 39.610.000 $ | +20.489.439 $ | +107,2 % | 1 | 19.120.561 $ | +19.120.561 $ | 1 | |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Neutral | 13.601.175 $ | -21.722.025 $ | -61,5 % | 1 | 35.323.200 $ | +0 $ | +0,0 % | 1 | 35.323.200 $ | +35.323.200 $ | 1 | |
| Rezolute, Inc. | RZLT | → 0 | Neutral | 32.760.000 $ | +13.545.000 $ | +70,5 % | 1 | 19.215.000 $ | +4.377.312 $ | +29,5 % | 1 | 14.837.688 $ | +14.837.688 $ | 1 | |
| TG THERAPEUTICS, INC. | TGTX | → 0 | Neutral | 29.392.900 $ | +11.620.200 $ | +65,4 % | 1 | 17.772.700 $ | +1.824.350 $ | +11,4 % | 1 | 15.948.350 $ | +15.948.350 $ | 1 | |
| SANUWAVE Health, Inc. | SNWV | → 0 | Neutral | 3.061.400 $ | -13.904.706 $ | -82,0 % | 1 | 16.966.106 $ | -12.314.901 $ | -42,1 % | 1 | 29.281.007 $ | +29.281.007 $ | 1 | |
| Immix Biopharma, Inc. | IMMX | → 0 | Neutral | 24.176.950 $ | +24.176.950 $ | 1 | |||||||||
| CRESCENT BIOPHARMA, INC. | CBIO | → 0 | Neutral | 23.748.318 $ | -364.420 $ | -1,5 % | 1 | 24.112.738 $ | +10.138.100 $ | +72,5 % | 1 | 13.974.638 $ | +13.974.638 $ | 1 | |
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 22.904.000 $ | +112.000 $ | +0,5 % | 1 | 22.792.000 $ | +732.700 $ | +3,3 % | 1 | 22.059.300 $ | +22.059.300 $ | 1 | |
| Alpha Cognition Inc. | ACOG | → 0 | Neutral | 20.905.272 $ | +6.840.166 $ | +48,6 % | 1 | 14.065.106 $ | +605.010 $ | +4,5 % | 1 | 13.460.096 $ | +13.460.096 $ | 1 | |
| Perspective Therapeutics, Inc. | CATX | → 0 | Schwach | 20.328.750 $ | +15.338.875 $ | +307,4 % | 1 | 4.989.875 $ | +4.989.875 $ | 1 | |||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 20.315.000 $ | +4.565.000 $ | +29,0 % | 1 | 15.750.000 $ | +3.342.500 $ | +26,9 % | 1 | 12.407.500 $ | +12.407.500 $ | 1 | |
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Sehr schwach | 5.892.000 $ | +810.000 $ | +15,9 % | 1 | 5.082.000 $ | -14.281.300 $ | -73,8 % | 1 | 19.363.300 $ | +19.363.300 $ | 1 | |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 18.728.000 $ | +9.003.000 $ | +92,6 % | 1 | 9.725.000 $ | +1.760.000 $ | +22,1 % | 1 | 7.965.000 $ | +7.965.000 $ | 1 | |
| Monte Rosa Therapeutics, Inc. | GLUE | → 0 | Schwach | 18.029.000 $ | +18.029.000 $ | 1 | |||||||||
| CG Oncology, Inc. | CGON | → 0 | Schwach | 1.263.908 $ | -5.152.156 $ | -80,3 % | 1 | 6.416.064 $ | -10.607.136 $ | -62,3 % | 1 | 17.023.200 $ | +17.023.200 $ | 1 | |
| ALUMIS INC. | ALMS | → 0 | Sehr schwach | 15.477.000 $ | +3.360.500 $ | +27,7 % | 1 | 12.116.500 $ | +6.894.900 $ | +132,0 % | 1 | 5.221.600 $ | +5.221.600 $ | 1 | |
| CODEXIS, INC. | CDXS | → 0 | Neutral | 15.334.100 $ | +4.274.550 $ | +38,7 % | 1 | 11.059.550 $ | -7.723 $ | -0,1 % | 1 | 11.067.273 $ | +11.067.273 $ | 1 | |
| Replimune Group, Inc. | REPL | → 0 | Neutral | 15.331.873 $ | +15.331.873 $ | 1 | |||||||||
| XOMA Royalty Corp | XOMA | → 0 | 14.380.895 $ | +4.969.895 $ | +52,8 % | 1 | 9.411.000 $ | +1.631.032 $ | +21,0 % | 1 | 7.779.968 $ | +7.779.968 $ | 1 | ||
| MBX Biosciences, Inc. | MBX | → 0 | Neutral | 14.352.000 $ | +6.591.000 $ | +84,9 % | 1 | 7.761.000 $ | -439.400 $ | -5,4 % | 1 | 8.200.400 $ | +8.200.400 $ | 1 | |
| Alkermes plc. | ALKS | → 0 | Sehr stark | 13.710.200 $ | +13.710.200 $ | 1 | |||||||||
| Annexon, Inc. | ANNX | → 0 | Neutral | 9.789.515 $ | -3.128.441 $ | -24,2 % | 1 | 12.917.956 $ | -134.044 $ | -1,0 % | 1 | 13.052.000 $ | +13.052.000 $ | 1 | |
| Editas Medicine, Inc. | EDIT | → 0 | Neutral | 12.512.653 $ | +7.752.970 $ | +162,9 % | 1 | 4.759.683 $ | +4.759.683 $ | 1 | |||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Schwach | 12.258.000 $ | +1.718.000 $ | +16,3 % | 1 | 10.540.000 $ | +1.369.300 $ | +14,9 % | 1 | 9.170.700 $ | +9.170.700 $ | 1 | |
| Cabaletta Bio, Inc. | CABA | → 0 | Neutral | 12.016.418 $ | +8.304.218 $ | +223,7 % | 1 | 3.712.200 $ | +1.741.200 $ | +88,3 % | 1 | 1.971.000 $ | +1.971.000 $ | 1 | |
| Q32 Bio Inc. | QTTB | → 0 | Neutral | 11.860.940 $ | +3.795.956 $ | +47,1 % | 1 | 8.064.984 $ | +7.356.619 $ | +1.038,5 % | 1 | 708.365 $ | +708.365 $ | 1 | |
| Gossamer Bio, Inc. | GOSS | → 0 | Sehr schwach | 8.432.000 $ | +8.432.000 $ | 1 | |||||||||
| Journey Medical Corp | DERM | → 0 | Neutral | 2.478.000 $ | -2.024.400 $ | -45,0 % | 1 | 4.502.400 $ | -3.014.850 $ | -40,1 % | 1 | 7.517.250 $ | +7.517.250 $ | 1 | |
| Verastem, Inc. | VSTM | → 0 | Neutral | 6.876.000 $ | +6.876.000 $ | 1 | |||||||||
| Zentalis Pharmaceuticals, Inc. | ZNTL | → 0 | Neutral | 6.851.382 $ | +3.545.767 $ | +107,3 % | 1 | 3.305.615 $ | +1.414.392 $ | +74,8 % | 1 | 1.891.223 $ | +1.891.223 $ | 1 | |
| Karyopharm Therapeutics Inc. | KPTI | → 0 | Sehr schwach | 6.844.800 $ | +6.844.800 $ | 1 | |||||||||
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 3.221.900 $ | -2.785.992 $ | -46,4 % | 1 | 6.007.892 $ | -590.099 $ | -8,9 % | 1 | 6.597.991 $ | +6.597.991 $ | 1 | |
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 6.470.200 $ | -37.400 $ | -0,6 % | 1 | 6.507.600 $ | +1.991.550 $ | +44,1 % | 1 | 4.516.050 $ | +4.516.050 $ | 1 | |
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 5.781.500 $ | +1.664.457 $ | +40,4 % | 1 | 4.117.043 $ | -203.609 $ | -4,7 % | 1 | 4.320.652 $ | +4.320.652 $ | 1 | |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Schwach | 5.334.000 $ | +4.857.126 $ | +1.018,5 % | 1 | 476.874 $ | +476.874 $ | 1 | |||||
| Assertio Holdings, Inc. | ASRT | → 0 | 5.064.375 $ | +2.479.425 $ | +95,9 % | 1 | 2.584.950 $ | +2.584.950 $ | 1 | ||||||
| Lyell Immunopharma, Inc. | LYEL | → 0 | Schwach | 4.833.551 $ | +3.246.865 $ | +204,6 % | 1 | 1.586.686 $ | +1.586.686 $ | 1 | |||||
| SUTRO BIOPHARMA, INC. | STRO | → 0 | Neutral | 4.749.615 $ | +2.543.552 $ | +115,3 % | 1 | 2.206.063 $ | +2.206.063 $ | 1 | |||||
| Voyager Therapeutics, Inc. | VYGR | → 0 | Schwach | 4.147.500 $ | -291.500 $ | -6,6 % | 1 | 4.439.000 $ | -264.833 $ | -5,6 % | 1 | 4.703.833 $ | +4.703.833 $ | 1 | |
| Opus Genetics, Inc. | IRD | → 0 | Neutral | 4.623.750 $ | +2.372.550 $ | +105,4 % | 1 | 2.251.200 $ | +0 $ | +0,0 % | 1 | 2.251.200 $ | +2.251.200 $ | 1 | |
| Tectonic Therapeutic, Inc. | TECX | → 0 | Neutral | 3.801.930 $ | -677.692 $ | -15,1 % | 1 | 4.479.622 $ | +4.479.622 $ | 1 | |||||
| Protalix BioTherapeutics, Inc. | PLX | → 0 | Neutral | 737.800 $ | -3.722.917 $ | -83,5 % | 1 | 4.460.717 $ | +4.460.717 $ | 1 | |||||
| 4D Molecular Therapeutics, Inc. | FDMT | → 0 | Schwach | 4.448.012 $ | +3.402.583 $ | +325,5 % | 1 | 1.045.429 $ | +1.045.429 $ | 1 | |||||
| Intellia Therapeutics, Inc. | NTLA | → 0 | Schwach | 4.230.000 $ | +1.089.100 $ | +34,7 % | 1 | 3.140.900 $ | +3.140.900 $ | 1 | |||||
| BIODESIX INC | BDSX | → 0 | Neutral | 4.059.000 $ | +607.318 $ | +17,6 % | 1 | 3.451.682 $ | +3.451.682 $ | 1 | |||||
| Fortress Biotech, Inc. | FBIO | → 0 | Neutral | 2.723.400 $ | -183.780 $ | -6,3 % | 1 | 2.907.180 $ | -1.082.220 $ | -27,1 % | 1 | 3.989.400 $ | +3.989.400 $ | 1 | |
| ROCKET PHARMACEUTICALS, INC. | RCKT | → 0 | Neutral | 3.420.000 $ | +1.100 $ | +0,0 % | 1 | 3.418.900 $ | +66.850 $ | +2,0 % | 1 | 3.352.050 $ | +3.352.050 $ | 1 | |
| RIGEL PHARMACEUTICALS INC | RIGL | → 0 | Sehr stark | 1.892.800 $ | -1.105.300 $ | -36,9 % | 1 | 2.998.100 $ | +2.998.100 $ | 1 | |||||
| Zymeworks Inc. | ZYME | → 0 | Schwach | 2.868.101 $ | +2.868.101 $ | 1 | |||||||||
| Ventyx Biosciences, Inc. | VTYX | → 0 | 2.274.946 $ | +2.274.946 $ | 1 | ||||||||||
| Phathom Pharmaceuticals, Inc. | PHAT | → 0 | Neutral | 2.013.641 $ | +2.013.641 $ | 1 | |||||||||
| Inhibrx Biosciences, Inc. | INBX | → 0 | Sehr schwach | 1.922.572 $ | +1.922.572 $ | 1 | |||||||||
| ENANTA PHARMACEUTICALS INC | ENTA | → 0 | Neutral | 1.822.500 $ | +243.750 $ | +15,4 % | 1 | 1.578.750 $ | +396.000 $ | +33,5 % | 1 | 1.182.750 $ | +1.182.750 $ | 1 | |
| Generation Bio Co. | GBIO | → 0 | 1.760.800 $ | +1.760.800 $ | 1 | ||||||||||
| Hemab Therapeutics Holdings, Inc. | COAG | → 0 | Neutral | 1.750.258 $ | +1.750.258 $ | 1 | |||||||||
| Atea Pharmaceuticals, Inc. | AVIR | → 0 | Neutral | 1.092.750 $ | -642.838 $ | -37,0 % | 1 | 1.735.588 $ | +1.093.648 $ | +170,4 % | 1 | 641.940 $ | +641.940 $ | 1 | |
| NextCure, Inc. | NXTC | → 0 | Schwach | 1.507.813 $ | +1.507.813 $ | 1 | |||||||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Schwach | 1.401.220 $ | +1.401.220 $ | 1 | |||||||||
| First Tracks Biotherapeutics, Inc. | TRAX | → 0 | Neutral | 1.307.800 $ | +1.307.800 $ | 1 | |||||||||
| Biohaven Ltd. | BHVN | → 0 | Schwach | 1.159.375 $ | +1.159.375 $ | 1 | |||||||||
| Pasithea Therapeutics Corp. | KTTA | → 0 | 1.056.570 $ | +1.056.570 $ | 1 | ||||||||||
| ADC Therapeutics SA | ADCT | → 0 | Schwach | 749.000 $ | +749.000 $ | 1 | |||||||||
| OKYO Pharma Ltd | OKYO | → 0 | 562.806 $ | +562.806 $ | 1 | ||||||||||
| Silence Therapeutics plc | SLN | → 0 | Neutral | 479.870 $ | +479.870 $ | 1 | |||||||||
| LB PHARMACEUTICALS INC | LBRX | → 0 | Schwach | 357.718 $ | +357.718 $ | 1 | |||||||||
| PALATIN TECHNOLOGIES INC | PTN | → 0 | Schwach | 221.195 $ | +221.195 $ | 1 | |||||||||
| RAPT Therapeutics, Inc. | RAPT | → 0 | 213.363 $ | +213.363 $ | 1 | ||||||||||
| Adagio Medical Holdings, Inc. | ADGM | → 0 | Sehr schwach | 13.353 $ | -7.858 $ | -37,0 % | 1 | 21.211 $ | +2.029 $ | +10,6 % | 1 | 19.182 $ | +19.182 $ | 1 | |
| Gesamt | 1.104.182.260 $ | +383.401.930 $ | +67,5 % | 58 | 759.221.131 $ | +39.312.722 $ | +64,5 % | 53 | 757.893.709 $ | +757.893.709 $ | 54 | ||||